HK1006421A1 - Levobupivacaine useful for managing chronic pain - Google Patents

Levobupivacaine useful for managing chronic pain

Info

Publication number
HK1006421A1
HK1006421A1 HK98105742A HK98105742A HK1006421A1 HK 1006421 A1 HK1006421 A1 HK 1006421A1 HK 98105742 A HK98105742 A HK 98105742A HK 98105742 A HK98105742 A HK 98105742A HK 1006421 A1 HK1006421 A1 HK 1006421A1
Authority
HK
Hong Kong
Prior art keywords
levobupivacaine
pct
chronic pain
useful
sec
Prior art date
Application number
HK98105742A
Other languages
English (en)
Inventor
Hazel J Bardsley
Laurence Mather
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10743430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1006421(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of HK1006421A1 publication Critical patent/HK1006421A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
HK98105742A 1993-10-13 1998-06-19 Levobupivacaine useful for managing chronic pain HK1006421A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939321061A GB9321061D0 (en) 1993-10-13 1993-10-13 Analgestic agent and its use
PCT/GB1994/002248 WO1995010276A1 (en) 1993-10-13 1994-10-13 Levobupivacaine useful for managing chronic pain

Publications (1)

Publication Number Publication Date
HK1006421A1 true HK1006421A1 (en) 1999-02-26

Family

ID=10743430

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105742A HK1006421A1 (en) 1993-10-13 1998-06-19 Levobupivacaine useful for managing chronic pain

Country Status (16)

Country Link
US (1) US5955479A (xx)
EP (1) EP0723444B1 (xx)
JP (1) JPH09503777A (xx)
KR (1) KR100343314B1 (xx)
CN (1) CN1074919C (xx)
AT (1) ATE154758T1 (xx)
AU (1) AU692477B2 (xx)
CA (1) CA2173208C (xx)
DE (1) DE69403969T2 (xx)
DK (1) DK0723444T3 (xx)
ES (1) ES2105766T3 (xx)
GB (1) GB9321061D0 (xx)
GR (1) GR3024787T3 (xx)
HK (1) HK1006421A1 (xx)
NO (1) NO309304B1 (xx)
WO (1) WO1995010276A1 (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU224226B1 (hu) * 1995-04-13 2005-06-28 Darwin Discovery Limited Levobupivacaine alkalmazása terhesség esetén használható érzéstelenítő hatású gyógyszerkészítmény előállítására
GB9704370D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
GB9704352D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
CA2297097C (en) * 1997-07-21 2009-04-07 Astra Aktiebolag Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
DK0998287T3 (da) * 1997-07-22 2003-09-01 Darwin Discovery Ltd Anvendelse af levobupivacain
ATE535232T1 (de) 1997-09-18 2011-12-15 Pacira Pharmaceuticals Inc Retardierte freisetzung liposomaler anesthetischer zusammensetzungen
JP4575592B2 (ja) 1997-11-14 2010-11-04 パシラ ファーマシューティカルズ インコーポレーテッド 多小胞リポソームの製造
BR9814883A (pt) * 1997-11-19 2000-10-03 Darwin Discovery Ltd Formulação anestésica
DE69940735D1 (de) 1998-07-17 2009-05-28 Pacira Pharmaceuticals Inc Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen
BR0002246A (pt) 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
JP2004532252A (ja) * 2001-05-31 2004-10-21 スカイファーマ インコーポレーテッド リポソームおよびミクロスフェア中のナノ懸濁物のカプセル化
JP2005519873A (ja) 2001-11-14 2005-07-07 アルザ・コーポレーション カテーテル注入可能なデポー組成物およびそれらの使用
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
IL166418A0 (en) 2002-07-31 2006-01-15 Alza Corp Injectable depot compositions and uses thereof
US8501215B2 (en) 2002-07-31 2013-08-06 Guohua Chen Injectable multimodal polymer depot compositions and uses thereof
DK2117521T3 (da) 2006-11-03 2012-09-03 Durect Corp Transdermale indgivelsessystemer omfattende bupivacain
DE102008037682A1 (de) * 2008-08-14 2010-04-08 Strackharn, Klaus, Dr.med. Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
CN105764491A (zh) 2013-12-09 2016-07-13 度瑞公司 药物活性剂复合物、聚合物复合物，以及包括其的组合物和方法
BR112019013192A2 (pt) * 2016-12-26 2019-12-10 Cellix Bio Private Ltd composto e composição farmacêutica
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11890422B2 (en) 2022-05-05 2024-02-06 Pfof Llc Anesthetic nerve block and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
WO1995010277A1 (en) * 1993-10-13 1995-04-20 Chiroscience Limited Analgesic agent and its use
ITTO20010597A1 (it) * 2001-06-20 2002-12-20 Plaset Spa Pompa per liquidi, in particolare pompa centrifuga per apparecchi elettrodomestici.

Also Published As

Publication number Publication date
ATE154758T1 (de) 1997-07-15
CN1074919C (zh) 2001-11-21
EP0723444A1 (en) 1996-07-31
NO961478L (no) 1996-06-11
EP0723444B1 (en) 1997-06-25
WO1995010276A1 (en) 1995-04-20
JPH09503777A (ja) 1997-04-15
US5955479A (en) 1999-09-21
NO961478D0 (no) 1996-04-12
AU692477B2 (en) 1998-06-11
GR3024787T3 (en) 1998-01-30
CA2173208A1 (en) 1995-04-20
ES2105766T3 (es) 1997-10-16
DE69403969D1 (de) 1997-07-31
CA2173208C (en) 2007-01-30
DK0723444T3 (da) 1997-12-29
NO309304B1 (no) 2001-01-15
KR100343314B1 (ko) 2003-02-19
GB9321061D0 (en) 1993-12-01
CN1133009A (zh) 1996-10-09
DE69403969T2 (de) 1997-11-20
AU7859394A (en) 1995-05-04

Similar Documents

Publication Publication Date Title
GR3024787T3 (en) Levobupivacaine useful for managing chronic pain
EP0792156A4 (en) METHOD FOR PREVENTING OR TREATING VASCULAR HEMORRAGIES AND ALZHEIMERIC DISEASE
HU9301978D0 (en) Application of complementary inhibitors in medical preparatives used for treatment of inflammatory diseases of intestines and skin
EP0831832A4 (en) METHODS FOR CONTROLLING INFECTIOUS DISEASES USING DICATIONIC BIS-BENZIMIDAZOLES
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
MY113059A (en) Controlled-release dosage forms of azithromycin
NO952229L (no) Anvendelse av karbamazepin og okskarbazepin ved behandling av neurologiske lesjoner relatert til traumatiske skader
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
ATE213411T1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
NO943049D0 (no) Anvendelse av 4-aminopyridin ved behandling av en nevrologisk tilstand
HK1020867A1 (en) The topical use of kappa opioid agonists to treat ocular pain k
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
EP1056458A4 (en) METHODS FOR TREATING PAIN, INCLUDING CHRONIC AND WOMAN-SPECIFIC PAIN
GB9500024D0 (en) Treatment of excessive cell proliferation disorders
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
ATE150645T1 (de) Verwendung von bmy 14802 zur behandlung von angstzuständen bei patienten mit benzodiazepin- entzugserscheinungen
UA36490A (uk) Спосіб лікування гнійно-септичних захворювань м'яких тканин
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору
GR3027682T3 (en) 4-guanidinobutyramide for improving blood circulation.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20141012